ECOR Projected Dividend Yield

ElectroCore Inc ( NASDAQ : ECOR )

ElectroCore is a commercial stage medical device company with a non-invasive vagus nerve stimulation (nVNS) therapy, called gammaCore. nVNS is a platform bioelectronic medical therapy that modulates neurotransmitters and immune function through its effects on both the peripheral and central nervous systems. Co.'s gammaCore therapy is prescription-only, with patients self-administering discrete doses using a handheld unit. Co.'s primary model, gammaCore Sapphire is a portable, reusable, rechargeable and reloadable option for patients, with the prescription being written by a health care provider and dispensed from a specialty pharmacy or fulfilled from its facility in Rockaway, NJ.

20 YEAR PERFORMANCE RESULTS